Health Security Before the First Case: Why Ebola Preparedness Must Move UpstreamGlobal Biodefense StaffJune 25, 2026
Preparedness When Ebola Emerges, This Network of U.S. Labs Is Already Standing ReadyGlobal Biodefense StaffJune 25, 2026
Preparedness Planning for the Unthinkable: Experts Chart a Path for Post-Nuclear Health SurveillanceGlobal Biodefense StaffJune 16, 2026
Preparing for Bioterrorism: Sloan’s Impact on Biosecurity and Biodefense Biosecurity December 13, 2012 …
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …
